Qiangnao Technology Clinches ~20 Billion Yuan Mega-Round: Second Biggest Brain-Computer Interface Bet After Neuralink

Qiangnao Technology, recognized as one of Hangzhou’s ‘Six Little Dragons,’ just locked in a massive funding round worth approximately 20 billion yuan, marking a significant milestone in the brain-computer interface sector. This positions the company as the second-largest funded venture in the field globally, trailing only Elon Musk’s Neuralink.

What’s the Money Going Toward?

The freshly raised capital will be channeled into three core areas: accelerating brain-computer interface technology development, achieving major engineering breakthroughs, and ramping up production capacity. According to Qiangnao Technology representatives, the funding strategy reflects confidence in both the technical feasibility and market potential of their brain-computer interface solutions.

The Real Play: Reshaping Lives Through Neuro-Tech

Beyond just advancing technology, Qiangnao Technology has set ambitious humanitarian goals. Within the next five to ten years, the company aims to enable one million people with physical disabilities to regain daily functionality through neuro-controlled prosthetics—powered by brain-computer interface innovation. That’s not just a tech flex; it’s about reintegration into society.

The vision extends further: the company plans to improve outcomes for ten million patients battling neurological conditions including autism, ADHD, Alzheimer’s disease, and insomnia. These applications demonstrate how brain-computer interface technology could transcend mobility assistance and touch neurodevelopmental and age-related challenges.

The Bigger Picture: Humans + Machines Reimagined

Qiangnao Technology isn’t stopping there. The long-term vision encompasses a future where ordinary people—not just those with disabilities—interact directly with the physical and digital world through brain-computer interface devices. This represents a fundamental reshaping of human-machine integration, moving from traditional peripherals to direct neural pathways.

With this substantial capital injection, the company is now positioned to bridge the gap between scientific research and real-world deployment of brain-computer interface solutions at scale.